To Investigate the Role of Upstream High Dose Statin in STEMI
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a double-blinded randomized placebo controlled trial investigating the role of
upstream 80mg Atorvastastin-calcium in patients undergoing percutaneous intervention for
acute STEMI.